Oak Longevity vs PeterMD: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Oak Longevity beats PeterMD overall, scoring 7.5/10 vs 7.3/10. Oak Longevity is more affordable at $133/mo vs $165/mo. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound. Choose PeterMD for budget-conscious users looking for the lowest monthly glp-1 .
A side-by-side look at Oak Longevity and PeterMD to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Oak Longevity
#25 of 53Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing, patients pay each month manually rather than auto-renew.
Visit Oak LongevityPeterMD
#32 of 53One of the most affordable compounded GLP-1 options on the market, ideal for budget-conscious patients.
Visit PeterMD| Feature | Oak Longevity | PeterMD |
|---|---|---|
| Our Score | 7.5/10 | 7.3/10 |
| Starting Price | $133/mo | $165/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin) | Budget-conscious users looking for the lowest monthly GLP-1 cost |
| Watch out for | Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare sells Wegovy direct at $349/mo and LillyDirect has Zepbound at $299/mo. Use Oak for its compounded tiers and buy brand-name direct | Available in 42 states, not all 50 (8 states are excluded). Check your state during signup before planning around PeterMD. |
| Ranking | #25 | #32 |
| Get started | Visit Oak Longevity | Visit PeterMD |
Pros & Cons Compared
Oak Longevity
Pros
- +$133/mo for compounded semaglutide is among the cheapest entries on the market, Sesame Care ($99) is lower, but Oak undercuts most mid-tier platforms
- +No-subscription model, patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
- +Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist
- +Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
- +Money-back guarantee if not approved by physician, useful safety net for borderline-eligibility patients
- +Free shipping and free health coaching included in every program
Cons
- −Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare sells Wegovy direct at $349/mo and LillyDirect has Zepbound at $299/mo. Use Oak for its compounded tiers and buy brand-name direct
- −No published lab panels and no specialty (obesity medicine) physicians disclosed, clinical oversight is lighter than lab-driven platforms
- −The 'up to 50% cheaper than competitors' marketing claim is unverified and inconsistent, judge Oak on its posted prices, which are genuinely low, not on the slogan
- −The longevity add-ons (NAD+, Sermorelin, Tesamorelin) have limited clinical evidence for weight loss specifically, if weight loss is the goal, the GLP-1 alone does the work and the stack is optional
- −Newer brand without disclosed company history, founding date, or executive team on landing pages
- −Three-month plans are billed upfront, start on the 1-month plan if you're testing the platform, then bundle once it fits
PeterMD
Pros
- +Flat $165/mo at all dose levels, price doesn't increase as you titrate up to maintenance doses
- +100,000+ patient base with 4.9/5 Trustpilot rating from 14,000+ reviews, strong social proof
- +Semaglutide + B12 formulation helps reduce nausea, the most common GLP-1 side effect
- +Video consultations with physicians included, real face-to-face medical oversight
Cons
- −Available in 42 states, not all 50 (8 states are excluded). Check your state during signup before planning around PeterMD.
- −Not BBB accredited, and some documented complaints cite delayed medication fulfillment. Order refills ahead of your last dose rather than at the last minute.
- −PeterMD began as a testosterone replacement therapy platform; GLP-1 is an expansion, not the original core. The included video consultations give you a direct read on the clinical team.
Our Verdict
Oak Longevity edges out PeterMD with a score of 7.5/10 vs 7.3/10. If budget is your priority, Oak Longevity starts at $133/mo compared to PeterMD's $165/mo. Oak Longevity offers both brand-name and compounded medications, giving you more flexibility. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin). Choose PeterMD if you want: budget-conscious users looking for the lowest monthly glp-1 cost.
Still undecided? Editor's Featured Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither Oak Longevity nor PeterMD feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing Oak Longevity or PeterMD tend to look at next.
- Oak Longevity vs Found$129/mo
- Oak Longevity vs GobyMeds$169/mo
- Oak Longevity vs bmiMD$119/mo
- PeterMD vs Maximus$150/mo
- PeterMD vs TrimRx$149/mo
- PeterMD vs Strut Health$149/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.